FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Fund ProfileiShares Neuroscience and Healthcare ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
IBRN
iShares Neuroscience and Healthcare ETF ETF AnalysisComprehensive ETF analysis for iShares Neuroscience and Healthcare ETF (IBRN) including NAV, expense ratio, dividend yield, sector breakdown, and holdings data.ETF AnalysisIBRN
IBRN
iShares Neuroscience and Healthcare ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
IBRN
  1. Home
  2. Screener
  3. iShares Neuroscience and Healthcare ETFIBRNETF

iShares Neuroscience and Healthcare ETF

ETF
🇺🇸IBRN•AMEX•Equity
Fund size (USD)
$8.55M
Expense Ratio
0.47%
Yield (12 mo)
1.00%
Holdings
67

Your view on IBRN

iShares Neuroscience and Healthcare ETF

ETFIShares
🇺🇸IBRN•AMEX•Equity
Fund size (USD)
$8.55M
Expense Ratio
0.47%
Yield (12 mo)
1.00%
Holdings
67
Your view
Fund Overview

Overview

What the fund invests in, who runs it, and what it costs.

iShares Neuroscience and Healthcare ETF (IBRN) is an Equity fund from iShares, listed since 2022, with $8.5M in assets under management, a 0.47% expense ratio and a NAV of $34.18 USD.

Overview for iShares Neuroscience and Healthcare ETF

Fund Type
ETF
Fund Issuer
IShares
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
August 24, 2022
Domicile
US
Website
ishares.com/us/products/329137/ishares-neuroscience-and-healthcare-etf
Fund Type
ETF
Fund Issuer
IShares
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
August 24, 2022
Domicile
US
Website
ishares.com/us/products/329137/ishares-neuroscience-and-healthcare-etf
Fund Type
ETF
Fund Issuer
IShares
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
August 24, 2022
Domicile
US
Website
ishares.com/us/products/329137/ishares-neuroscience-and-healthcare-etf

About this fund

The iShares Neuroscience and Healthcare ETF seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.

Fund Data

Price Chart

Market price history and trading volume.

Key Facts

Cost, yield, size, and the fund's reference data.

Equity

Expense Ratio

0.47%

Yield (12 mo)

1.00%

Fund size

$8.55M

Fund Details

NAV$34.18 USD
Holdings67
Average Volume2.9K
Inception DateAugust 24, 2022
Asset ClassEquity
Fund IssuerIShares
DomicileUS
ISINUS46436E3532
CUSIP46436E353
NAV CurrencyUSD

Expense Ratio

0.47%

Dividend Yield (TTM)

1.00%

Assets Under Management

$8.55M

NAV

$34.18 USD

Holdings

67

Average Volume

2.9K

Inception Date

August 24, 2022

Asset Class

Equity

Fund Issuer

IShares

Domicile

US

ISIN

US46436E3532

CUSIP

46436E353

NAV Currency

USD

Expense Ratio

0.47%

Dividend Yield (TTM)

1.00%

Assets Under Management

$8.55M

NAV

$34.18 USD

Holdings

67

Average Volume

2.9K

Inception Date

August 24, 2022

Asset Class

Equity

Fund Issuer

IShares

Domicile

US

ISIN

US46436E3532

CUSIP

46436E353

NAV Currency

USD

Distributions · last 12 months

Annual · 1 payment

Ex-datePaidAmount
Dec 16, 2025Dec 19, 2025$0.3198
Total, 12 months$0.32 a share

Dividend yield (TTM) 1.00% = $0.32 paid per share in the 12 months to Nov 20, 2026 ÷ the $32.05 price. Past distributions; future payments can differ.

Data last updated: Nov 17, 2026, 08:10 AM

Sectors

How the fund's assets are split across sectors.

1 sectors
  • 1Healthcare
    100.0%

Top sector

Healthcare

Top weight

100.0%

Top 3 weight

100.0%

Holdings

The securities the fund owns, by weight.

76 positions
1BIIBBIOGEN
5.52%
2NBIXNEUROCRINE BIOSCIENCES
4.94%
3ALKSALKERMES
4.90%
4EWTXEDGEWISE THERAPEUTICS
4.68%
5AXGNAXOGEN
4.57%
6SRRKSCHOLAR ROCK HOLDING
4.47%
7ARGXARGENX SE ADR
4.46%
8PRAXPRAXIS PRECISION MEDICINES
4.33%
9PTCTPTC THERAPEUTICS
4.15%
10326030.KSSK BIOPHARMACEUTICALS LTD
3.97%
11DNTHDIANTHUS THERAPEUTICS
3.83%
12HLUN-B.COH. LUNDBECK CLASS B
3.78%
13DYNDYNE THERAPEUTICS
3.24%
14ACADACADIA PHARMACEUTICALS
3.09%
15XENEXENON PHARMACEUTICALS
3.09%

Concentration

Top 10 Weight46.00%
1BIIBBIOGEN
5.52%
2NBIXNEUROCRINE BIOSCIENCES
4.94%
3ALKSALKERMES
4.90%
4EWTXEDGEWISE THERAPEUTICS
4.68%
5AXGNAXOGEN
4.57%
6SRRKSCHOLAR ROCK HOLDING
4.47%
7ARGXARGENX SE ADR
4.46%
8PRAXPRAXIS PRECISION MEDICINES
4.33%
9PTCTPTC THERAPEUTICS
4.15%
10326030.KSSK BIOPHARMACEUTICALS LTD
3.97%
11DNTHDIANTHUS THERAPEUTICS
3.83%
12HLUN-B.COH. LUNDBECK CLASS B
3.78%
13DYNDYNE THERAPEUTICS
3.24%
14ACADACADIA PHARMACEUTICALS
3.09%
15XENEXENON PHARMACEUTICALS
3.09%

Top 10 Weight

46.00%

1BIIBBIOGEN
5.52%$451.3K
2NBIXNEUROCRINE BIOSCIENCES
4.94%$403.7K
3ALKSALKERMES
4.90%$400.7K
4EWTXEDGEWISE THERAPEUTICS
4.68%$382.6K
5AXGNAXOGEN
4.57%$373.1K
6SRRKSCHOLAR ROCK HOLDING
4.47%$365.0K
7ARGXARGENX SE ADR
4.46%$364.6K
8PRAXPRAXIS PRECISION MEDICINES
4.33%$353.5K
9PTCTPTC THERAPEUTICS
4.15%$338.7K
10326030.KSSK BIOPHARMACEUTICALS LTD
3.97%$324.5K
11DNTHDIANTHUS THERAPEUTICS
3.83%$313.1K
12HLUN-B.COH. LUNDBECK CLASS B
3.78%$308.8K
13DYNDYNE THERAPEUTICS
3.24%$264.5K
14ACADACADIA PHARMACEUTICALS
3.09%$252.3K
15XENEXENON PHARMACEUTICALS
3.09%$252.3K

Top 10 Weight

46.00%

Peer Comparison

Comparables

Funds similar to this one.

Side by side on what an ETF is compared on13 funds
FundAsset classExpense ratioAssetsHoldings
IBRNiShares Neuroscience and Healthcare ETFThis fundEquity0.47%$9M67

Comparable funds

  • DYLGGlobal X - Dow 30 Covered Call & Growth ETFEquity0.35%$5M31
  • EPMBHarbor Mid Cap Core ETF (EPMB)Equity0.88%$5M60
  • EPSVHarbor SMID Cap Value ETF (EPSV)Equity0.88%$6M60
  • ETECiShares Breakthrough Environmental Solutions ETFEquity0.47%$4M46
  • FOWFPacer Solactive Whitney Future of Warfare ETFEquity0.49%$14M96
  • ITDJiShares LifePath Target Date 2070 ETFMulti-Asset0.12%$18M6
  • SOLRSmartETFs Sustainable Energy II ETFEquity3.81%$5M68
  • TMDVProShares - Russell U.S. Dividend Growers ETFEquity0.35%$5M67

More IShares ETFs

  • XUU.TOiShares Core S&P U.S. Total Market Index ETFEquity0.07%$4.6B125
  • XVLU.TOiShares MSCI USA Value Factor Index ETFEquity0.32%$88M1
  • XVViShares ESG Select Screened S&P 500 ETFEquity0.08%$860M437
  • XWD.TOiShares MSCI World Index ETFEquity0.48%$1.7B4
  • XUT.TOiShares S&P/TSX Capped Utilities Index ETFEquity0.61%$465M13
Ownership & News

Fund Holders

Institutions that own shares of this fund.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for this company. Press releases and market coverage, newest first.